RCTs and prospective real-world studies have shown that use of continuous glucose monitoring (CGM) or intermittently scanned continuous glucose monitoring (isCGM) in people with type 2 diabetes on intensive insulin therapy through multiple daily injections is associated with lower HbA1c [4–6] and reductions in hypoglycaemia [7, 8]. Here, INS is linked to type 2 diabetes mellitus.